Literature DB >> 28700834

Petroleum ether extract of Njavara rice (Oryza sativa) bran upregulates the JAK2-STAT3-mediated anti-inflammatory profile in macrophages and aortic endothelial cells promoting regression of atherosclerosis.

Pushpan K Chithra1, Ananthasankaran Jayalekshmy2, Antony Helen1.   

Abstract

"Njavara" (Oryza sativa L.) is a unique rice variety grown in Kerala that is reported to have significantly higher antioxidant, anti-inflammatory, chemical indices, and bioactive components compared with staple rice varieties. However, the role of NBE in reversing the atherosclerosis development remains unclear. The present study aimed to elucidate the role of NBE in promoting atherosclerotic regression. Male New Zealand white breed rabbits were divided into three groups. Group I was the control, group II was the regression control, and group III was NBE treated (100 mg/kg body mass). Serum and tissue lipids, CRP, antioxidant enzyme activities, mRNA, and protein expression of genes of RTC and mRNA expression of cytokines were studied. The current study showed that hypercholesterolemic rabbits treated with NBE decreased the serum and tissue lipids concentrations, ApoB expression, and CRP levels and enhanced the activities of antioxidant enzymes and PON1expression, JAK2, STAT3, ABCA1, and ApoA. Our results indicate that NBE attenuates proinflammatory cytokine production (IL-1β), enhanced expression and interactions of ABCA1/ApoA1 leading to JAK2/STAT3 activation in macrophages switching to an anti-inflammatory milieu in the system, and enhanced expression of IL-10 and decreased expression of ApoB, indicating that treatment with NBE facilitates plaque regression.

Entities:  

Keywords:  ABCA1; JAK-STAT; Njavara; atherosclerosis; athérosclérose; regression; régression

Mesh:

Substances:

Year:  2017        PMID: 28700834     DOI: 10.1139/bcb-2017-0090

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  4 in total

1.  The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.

Authors:  Lara Campana; Philip J Starkey Lewis; Antonella Pellicoro; Rebecca L Aucott; Janet Man; Eoghan O'Duibhir; Sarah E Mok; Sofia Ferreira-Gonzalez; Eilidh Livingstone; Stephen N Greenhalgh; Katherine L Hull; Timothy J Kendall; Douglas Vernimmen; Neil C Henderson; Luke Boulter; Christopher D Gregory; Yi Feng; Stephen M Anderton; Stuart J Forbes; John P Iredale
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

2.  Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux.

Authors:  Idit Dotan; Jiaqi Yang; Jiro Ikeda; Ziv Roth; Evan Pollock-Tahiri; Harsh Desai; Tharini Sivasubramaniyam; Sonia Rehal; Josh Rapps; Yu Zhe Li; Helen Le; Gedaliah Farber; Edouard Alchami; Changting Xiao; Saraf Karim; Marcela Gronda; Michael F Saikali; Amit Tirosh; Kay-Uwe Wagner; Jacques Genest; Aaron D Schimmer; Vikas Gupta; Mark D Minden; Carolyn L Cummins; Gary F Lewis; Clinton Robbins; Jenny Jongstra-Bilen; Myron Cybulsky; Minna Woo
Journal:  Commun Biol       Date:  2022-02-15

3.  N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.

Authors:  Guo Dong; Jiangbo Yu; Gaojun Shan; Lide Su; Nannan Yu; Shusen Yang
Journal:  Front Cell Dev Biol       Date:  2021-12-07

4.  In silico analysis of the molecular regulatory networks in peripheral arterial occlusive disease.

Authors:  Xuwen Guan; Xiaoyan Yang; Chunming Wang; Renbing Bi
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.